Search for: "OSRAM GMBH V ITC"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
20 May 2009, 10:27 am
§ 1337(c); Osram GmbH v. [read post]
1 Nov 2007, 9:19 am
As a result, the court held a § 337 violation was made out, and remanded the case to the ITC for further proceedings.More detail of Osram GmbH v. [read post]
1 Jul 2011, 1:43 am
Vistaprint (EDTexweblog.com) MOSAID – ALJ Gildea sets target date in Certain Equipment for Communications Networks (337-TA-778) (ITC Law Blog) Osram – White light /White heat: Osram, LG and Samsung kick off global LED patent war (Green Patent Blog) Overland – ALJ Bullock denies motion to compel discovery from third-party in Certain Automated Media Library Devices (337-TA-746) (ITC Law Blog) Spansion – Initial determination terminates… [read post]
25 Apr 2008, 8:28 am
OSRAM GmbH after the jump, [More] [read post]
17 Jun 2011, 2:54 am
(Docket Report) District Court Delaware: Insurance claims processing patents declared invalid under Bilski: Accenture Global Services GmbH, et. al. v. [read post]
29 Feb 2012, 10:38 am
See Osram GmbH v. [read post]
4 Jun 2011, 4:13 pm
Ajinomoto, 597 F.3d at 1272; OSRAM GmbH v. [read post]
14 Aug 2011, 11:31 pm
(Chicago IP Litigation Blog) Crocs – ITC issues opinion on remedy, public interest, and bonding in Certain Foam Footwear (337-TA-567) (ITC 337 Law Blog) Hewlett Packard – ITC issues seizure and forfeiture order in Certain Inkjet Ink Supplies (337-TA-691) (ITC Law Blog) OSRAM GmbH – ALJ Bullock sets procedural schedule in Certain Light-Emitting Diodes (337-TA-785) (ITC Law Blog) Otter Products – ALJ Essex sets… [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
